Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Centers for Disease Control; Chart: Chris Canipe/Axios

Top public health officials today warned that sexually transmitted diseases continue to rise sharply — hitting a new U.S. record of nearly 2.3 million cases of chlamydia, gonorrhea and syphilis diagnosed in 2017, per preliminary Centers for Disease Control and Prevention data. The increase is attributed in part to a lack of federal funding for state public health programs, an increase in drug abuse, and socioeconomic problems.

Threat level: The CDC also says there are worrying indications that the current dual therapy antibiotic regime for gonorrhea could become ineffective if resistance, which has been rising in lab testing and reported in other countries, continues.

"There are challenges on many fronts ... [including] skyrocketing STDs and theoretical antibiotic resistance."
— Gail Bolan, director, CDC Division of STD Prevention

By the numbers, per CDC's preliminary 2017 data compared with 2013:

  • Gonorrhea rose by 67% overall (to 555,608 cases from 333,004), doubling among men and showing a "concerning" increase in women for the third year in a row.
  • Primary and secondary syphilis rose 76% (to 30,644 from 17,374), almost 70% of which are cases among gay, bisexual and other men who have sex with men.
  • Chlamydia rose by 21.9% (to 1.7 million from 1,401,906 million) and remains the most common condition. 45% were diagnosed in 15- to 24-year-olds.

Why it matters: These STDs are curable with antibiotics (for now), yet untreated cases are causing severe health problems like infertility, ectopic pregnancy, stillbirth in infants and higher risk of HIV infection.

Funding request: Michael Fraser, executive director of the Association of State and Territorial Health officials, says that one of the primary problems is lack of federal funding for state programs.

"This is primarily due to eroding public health infrastructure," Fraser said at a press briefing.

The National Coalition of STD Directors (NCSD), a partnership of public health professionals dedicated to the prevention of STDs, agrees. The group cited a 40% decrease since 2003 in the purchasing power of federal STD funding, and calls for an additional $70 million yearly to be added to the budget.

“It’s not a coincidence STDs are skyrocketing — state and local STD programs are working with effectively half the budget they had in the early 2000s... If our representatives are serious about protecting American lives, they will provide adequate funding to address this crisis. Right now, our STD prevention engine is running on fumes.”
— David Harvey, executive director, NCSD, in a statement

Editor's note: This piece has been updated with further information from the press briefing.

Go deeper

3 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.

The week markets went wild

Illustration: Lazaro Gamio

The markets just closed out a manic week.

Why it matters: Outsized — and in some cases historic — moves were evident across the board.